Nucleome Therapeutics nominates first preclinical development candidate First-in-class monoclonal antibody agonist programme for inflammation resolution with broad applicability across major chronic ...
VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to ...
EUGENE, OREGON, UNITES STATES OF AMERICA, August 13, 2024 /EINPresswire.com/ -- InVivo Biosystems, a trailblazer in the biotechnology industry, has unveiled ...
Diagnostic method development is booming, with advances arising both from scratch and built on existing tools. Here, we highlight a few of the recent strides taken toward the optimization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback